Daniel Bracey
Orthopaedic Surgery · Charlotte, NCNPI 1053721647
Payments from drug & device makers
Across 85 payments — averaging $153.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$4K
- Medical Device Business Services, Inc.$3K
- Smith+Nephew$2K
- Ortho Development Corporation$2K
- Corin USA$828
- Johnson & Johnson$370
- plus $1K from 9 others
What the payments were for
- Consulting fees$2,11516%
- Travel & lodging$6,24448%
- Food & beverage$4,71936%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 34 | $3,617 |
| Medical Device Business Services, Inc. | 7 | $3,183 |
| Smith+Nephew | 11 | $2,046 |
| Ortho Development Corporation | 6 | $1,937 |
| Corin USA | 3 | $828 |
| Johnson & Johnson(2 entities) | 7 | $370 |
| Omnilife Science, Inc | 4 | $289 |
| Innovation Technologies Inc | 3 | $218 |
| Stryker | 2 | $145 |
| Orthalign Inc | 3 | $138 |
| Total Joint Orthopedics, Inc. | 1 | $112 |
| Naviswiss, Inc. | 1 | $109 |
| Tricoast Surgical Solutions LLC | 1 | $44 |
| Medtronic | 1 | $31 |
| Orthosensor Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Entrada Hip Stem$1,864
- REAL INTELLIGENCE$1,279
- Persona Revision$1,223
- ATTUNE$942
- ACTIS$826
- Journey II$561
- Persona$432
- Taperloc$288
- G7$282
- Irrisept$136
- REDAPT$115
- MAKO$110
- ORTHALIGN PLUS$110
- Naviswiss Hip/Knee Navigation$109
- Legend$103
How this compares
$13,078 in reported general payments places this provider in the 65th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 15 | $237 |
| Oxycodone Hcl | 35 | $180 |
| Gabapentin | 17 | $143 |
| Amoxicillin | 62 | $114 |
| Meloxicam | 18 | $47 |
| Clindamycin Hcl | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Charlotte
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- John MasonCharlotte$6.2M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Carroll JonesCharlotte$3.9M
- John MasonisCharlotte$3.9M
- Patrick ConnorCharlotte$3M
- Bruce CohenCharlotte$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.